文献速递骨肌介入神经CT

脊柱骨样骨瘤:射频消融的疗效与安全性

Spinal osteoid osteoma: efficacy and safety of radiofrequency ablation.
PubMed 文献 · Skeletal Radiol · 2017-05-11

本研究评估CT引导下射频消融治疗脊柱骨样骨瘤的疗效与并发症,2002至2012年共纳入61例患者,平均随访41.5个月。初次消融后57例(93.4%)症状完全缓解,4例(6.5%)复发,出现1例并发症和1例可能并发症。作者认为CT引导下射频消融是脊柱骨样骨瘤的优良治疗方法,并建议将其作为该病的首选治疗。

要点

  • CT引导下射频消融治疗脊柱骨样骨瘤的初次症状完全缓解率为93.4%(57/61)。
  • 复发率为6.5%(4/61),复发均发生在术后3个月,其中2例再次射频消融,另2例改手术治疗。
  • 出现1例并发症(消融后下肢感觉异常持续30天)和1例可能并发症(椎间盘突出)。

核心结论

  • CT引导下射频消融是脊柱骨样骨瘤的优良治疗方法;作者认为该手术应被考虑作为该病的首选治疗。

研究设计与样本

  • 研究类型为评估CT引导下射频消融治疗脊柱骨样骨瘤疗效与并发症的临床研究;2002年至2012年共纳入61例患者(男46例、女15例,平均年龄26.4±12.7岁);骨样骨瘤诊断前疼痛和症状持续时间为20.6±14.4个月;射频消融在清醒镇静和局部镇痛下进行;平均随访41.5±7.1个月。

诊断标准与关键数值

  • 初次射频消融的疗效定义为症状完全消退;61例中57例(93.4%)获得初次疗效;4例(6.5%)在术后3个月出现复发。

临床应用与阅片要点

  • 作者认为CT引导下射频消融应被考虑作为脊柱骨样骨瘤的首选治疗;术后需随访症状缓解及复发情况,并注意下肢感觉异常和椎间盘突出等并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to evaluate the efficacy and complications of CT-guided radiofrequency ablation (RFA) of spinal osteoid osteoma (OO).

MATERIALS AND METHODS: Between 2002 and 2012, a total of 61 patients (46 male and 15 female, mean age 26.4 ± 12.7 years) were subjected to RFA for spinal OO. The diagnosis of OO was made after a period of pain and symptoms of 20.6 ± 14.4 months. RFA was performed under conscious sedation and local analgesia. Clinical symptoms were evaluated at 3, 6, and12 months, and at the end of the time of the present investigation. Mean follow-up was 41.5 ± 7.1 months.

RESULTS: The primary efficacy of RFA, complete regression of symptoms, was obtained in 57 out of 61 patients (93.4%). Four out of 61 (6.5%) patients showed a relapse of OO (after 3 months); 2 out of 4 were subjected to a second RFA, the remaining ones were subjected to surgery. There was one complication (case of lower limb paresthesia for 30 days after the ablation) and one possible complication (a disc herniation).

CONCLUSION: CT-guided RFA is an excellent treatment for spinal OO. Our data suggest that this procedure should be considered for the first stage of therapy for this disease.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Albisinni U, Facchini G, Spinnato P, et al. Spinal osteoid osteoma: efficacy and safety of radiofrequency ablation. Skeletal Radiol. 2017. PMID: 28497160. doi:10.1007/s00256-017-2662-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。